Literature DB >> 2292167

Therapeutic drug monitoring in pregnancy: rationale and current status.

C Knott1, F Reynolds.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2292167     DOI: 10.2165/00003088-199019060-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  67 in total

Review 1.  Pharmacokinetics in pregnancy and placental drug transfer.

Authors:  F Reynolds; C Knott
Journal:  Oxf Rev Reprod Biol       Date:  1989

2.  Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.

Authors:  G J Johnson; C J Kilpatrick; R W Bury; R O Fullinfaw; R F Moulds
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

Review 3.  Basic pharmacokinetics.

Authors:  R H Levy; L A Bauer
Journal:  Ther Drug Monit       Date:  1986       Impact factor: 3.681

4.  Infantile spasms on weaning from breast milk containing anticonvulsants.

Authors:  C Knott; F Reynolds; G Clayden
Journal:  Lancet       Date:  1987-08-01       Impact factor: 79.321

5.  Active metabolites of antidepressants: pharmacodynamics and relevant pharmacokinetics.

Authors:  W Z Potter; M V Rudorfer; E A Lane
Journal:  Adv Biochem Psychopharmacol       Date:  1984

Review 6.  Plasma level monitoring of antidepressants: theoretical basis and clinical application.

Authors:  L F Gram; P Kragh-Sørensen; C B Kristensen; M Møller; O L Pedersen; P Thayssen
Journal:  Adv Biochem Psychopharmacol       Date:  1984

7.  Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.

Authors:  C Knott; A Hamshaw-Thomas; F Reynolds
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-02

8.  In vitro protein binding interaction studies involving cefixime.

Authors:  M Bialer; W H Wu; R D Faulkner; B M Silber; A Yacobi
Journal:  Biopharm Drug Dispos       Date:  1988 May-Jun       Impact factor: 1.627

9.  Plasma concentrations of unbound valproate and the management of epilepsy.

Authors:  C J Kilpatrick; R W Bury; R O Fullinfaw; R F Moulds
Journal:  Aust N Z J Med       Date:  1987-12

10.  Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring.

Authors:  J Grevel; M S Welsh; B D Kahan
Journal:  Ther Drug Monit       Date:  1989       Impact factor: 3.681

View more
  4 in total

Review 1.  Clinical pharmacokinetics of neuromuscular relaxants in pregnancy.

Authors:  J Guay; Y Grenier; F Varin
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

Review 2.  Predicting effective drug concentrations for individual patients. Determinants of pharmacodynamic variability.

Authors:  G Levy
Journal:  Clin Pharmacokinet       Date:  1998-04       Impact factor: 6.447

Review 3.  Risk-benefit assessment of anaesthetic agents in the puerperium.

Authors:  J Kanto
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

Review 4.  Pharmacokinetics of valproate in pregnancy: mother-foetus-newborn.

Authors:  S I Johannessen
Journal:  Pharm Weekbl Sci       Date:  1992-06-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.